Evolving Market Trends In The RNA Targeting Small Molecule Drug Discovery Industry: Revolutionizing Small-Molecule Drug Discovery Through The Impact Of AI integration In Pharmaceutical Research

The RNA Targeting Small Molecule Drug Discovery Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected RNA Targeting Small Molecule Drug Discovery Market Size During the Forecast Period?
The market size for RNA targeting small molecule drug discovery has greatly expanded in recent times. With a projected growth from $1.76 billion in 2024 to $2.14 billion in 2025, the compound annual growth rate (CAGR) stands at 21.8%. A deeper comprehension of disease genetics, along with breakthroughs in the fields of genomics and proteomics, challenges surrounding drug resistance, investment in biotech and pharmaceutical research, and the emergence of RNA therapeutics are all contributing factors to the growth experienced during the historic period.

The market for RNA targeting small molecule drug discovery is predicted to experience significant growth in the coming years, reaching an estimated value of $4.92 billion in 2029, reflecting a compound annual growth rate (CAGR) of 23.1%. Factors contributing to this growth during the projected period include advancements in RNA epigenetics research, RNA-seq and functional genomics, the incorporation of artificial intelligence (AI), focus on patients, and exosome-mediated drug delivery methods. Furthermore, the predicted period anticipates the development of RNA editing technologies, advancements in CRISPR technology, technological innovations, developments in RNA biology, and the application of RNA targeting in neurodegenerative diseases.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12480

What Are the High-Growth Segments in the RNA Targeting Small Molecule Drug Discovery Market?
The RNA targeting small molecule drug discovery market covered in this report is segmented -

1) By Target RNA Type: Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)
2) By Technology: CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas
4) By Delivery Method: Intravenous (IV), Oral, Topical, Other Methods
5) By Application: Research Use, Therapeutic Use, Diagnostic Use, Other Applications

Subsegments:
1) By Messenger RNA (mRNA): Targeting mRNA For Protein Coding, Modulation Of mRNA Stability, mRNA Translation Inhibition
2) By Non-Coding RNA (ncRNA): Long Non-Coding RNA, Small Nuclear RNA, Small Nucleolar RNA
3) By MicroRNA (miRNA): miRNA Inhibition, miRNA Mimics, Targeting Specific miRNA Pathways
4) By Long Non-Coding RNA (lncRNA): lncRNA Modulators, Targeting Specific lncRNA Functions, Therapeutic Applications Of lncRNA

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12480&type=smp

What Key Drivers Are Expected to Influence Future RNA Targeting Small Molecule Drug Discovery Market Growth?
The rise in instances of cancer, genetic disorders, and viral infections are anticipated to fuel the expansion of the RNA-targeted small-molecule drug discovery market. Cancer is one of the disease groups defined by uncontrolled cell growth in the body, while viral infections are conditions caused by microscopic infectious agents that can only propagate within the cells of living beings. To treat these disorders, which are associated with gene-related issues and faulty genetic material, RNA-targeting based drug discovery is employed. For example, a report issued in February 2024 by the World Health Organization, a Switzerland-based international body, stated that there were roughly 20 million new cancer diagnoses and 9.7 million deaths worldwide in 2022. Lung cancer led the list with 2.5 million new cases (12.4%), followed by breast cancer in women (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million cases, 7.3%), and stomach cancer (970,000 cases, 4.9%). It is also forecasted that by 2050, new cancer diagnoses will surge by 77%, exceeding 35 million per year. Consequently, the escalating prevalence of cancer, genetic disorders, and viral infections propels the advancement of the RNA-targeted small-molecule drug discovery market.

Which Companies Hold the Largest Share Across Different RNA Targeting Small Molecule Drug Discovery Market Segments?
Major companies operating in the RNA targeting small molecule drug discovery market include F. Hoffmann-La Roche Ltd, Merck & Co. Inc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Moderna Inc., Astellas Pharma Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Arrakis Therapeutics, Arbutus Biopharma Corporation, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics, Expansion Therapeutics

What Trends Are Driving Growth in The RNA Targeting Small Molecule Drug Discovery Market?
The incorporation of artificial intelligence (AI) into drug discovery processes is a significant trend gaining traction in the small molecule drug discovery market. Leading companies within this market are capitalizing on AI technologies to speed up drug discovery efforts and maintain their market dominance. For example, in May 2023, Google Cloud, the cloud computing arm of the US-based tech company, Google, introduced both the Target and Lead Identification Suite and the Multiomics Suite, aiming to streamline the drug discovery procedure. The Multiomics Suite accelerates the pinpointing and analysis of genetic data, thus helping companies to create precision medicines. Moreover, the Target and Lead Identification Suite provides researchers with valuable insights into the function of amino acids and prediction of protein structure.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecule-drug-discovery-global-market-report

What Are the Emerging Geographies for The RNA Targeting Small Molecule Drug Discovery Market Growth?
North America was the largest region in the RNA-targeting small molecule drug discovery market in 2024. The regions covered in the RNA targeting small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the RNA Targeting Small Molecule Drug Discovery Market?
2. What is the CAGR expected in the RNA Targeting Small Molecule Drug Discovery Market?
3. What Are the Key Innovations Transforming the RNA Targeting Small Molecule Drug Discovery Industry?
4. Which Region Is Leading the RNA Targeting Small Molecule Drug Discovery Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.